Functional polymorphisms in Nrf2: implications for human disease

被引:61
作者
Cho, Hye-Youn [1 ]
Marzec, Jacqui [1 ]
Kleeberger, Steven R. [1 ]
机构
[1] NIEHS, Inflammat Immun & Dis Lab, NIH, Res Triangle Pk, NC 27709 USA
基金
美国国家卫生研究院;
关键词
Somatic; Mutations; Complex disease; Genetic; Promoter; Antioxidant response element; Mouse; Genome-wide association; NRF2-ENCODING NFE2L2 HAPLOTYPES; GENE PROMOTER POLYMORPHISM; TRANSCRIPTION FACTOR NRF2; ANNUAL DECLINE; E3; LIGASE; KEAP1; ASSOCIATION; MUTATIONS; CANCER; RISK;
D O I
10.1016/j.freeradbiomed.2015.06.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor (erythroid derived)-2 like 2 (NFE2L2), also known as nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2), is a ubiquitous transcription factor essential for protecting cells and tissues from oxidative stress-induced injury. Positional cloning and studies with Nrf2 knockout mice have identified important roles for this transcription factor in disease phenotypes for many organ systems. Studies have also characterized the means through which human Nrf2 is regulated and the mechanisms of interaction with antioxidant response elements (ARE) in promoters of effector genes. Moreover, single nucleotide polymorphisms (SNPs) in Nrf2 have been identified and evaluated for effects on gene expression and function, and translational investigations have sought to determine whether loss of function SNPs associate with disease progression. In this review, we present 1) an overview of the human Nrf2 gene and protein domain, 2) identification of genetic mutations in Nrf2 and associations of the mutations with multiple diseases, and 3) the role of somatic mutations in Nrf2 in diseases, primarily various cancers.
引用
收藏
页码:362 / 372
页数:11
相关论文
共 80 条
[11]   NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development [J].
Chan, KM ;
Lu, RH ;
Chang, JC ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13943-13948
[12]   Linkage analysis of susceptibility to hyperoxia -: Nrf2 is a candidate gene [J].
Cho, HY ;
Jedlicka, AE ;
Reddy, SPM ;
Zhang, LY ;
Kensler, TW ;
Kleeberger, SR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (01) :42-51
[13]   Association of Nrf2 Polymorphism Haplotypes with Acute Lung Injury Phenotypes in Inbred Strains of Mice [J].
Cho, Hye-Youn ;
Jedlicka, Anne E. ;
Gladwell, Wesley ;
Marzec, Jacqui ;
McCaw, Zackary R. ;
Bienstock, Rachelle J. ;
Kleeberger, Steven R. .
ANTIOXIDANTS & REDOX SIGNALING, 2015, 22 (04) :325-338
[14]   Genomic Structure and Variation of Nuclear Factor (Erythroid-Derived 2)-Like 2 [J].
Cho, Hye-Youn .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2013, 2013
[15]   Nrf2 protects against airway disorders [J].
Cho, Hye-Youn ;
Kleeberger, Steven R. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 244 (01) :43-56
[16]   Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity [J].
Chowdhry, S. ;
Zhang, Y. ;
McMahon, M. ;
Sutherland, C. ;
Cuadrado, A. ;
Hayes, J. D. .
ONCOGENE, 2013, 32 (32) :3765-3781
[17]   The NRF2 gene variant,-653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus [J].
Cordova, E. J. ;
Velazquez-Cruz, R. ;
Centeno, F. ;
Baca, V. ;
Orozco, L. .
LUPUS, 2010, 19 (10) :1237-1242
[18]  
Eichenmüller M, 2014, J HEPATOL, V61, P1312, DOI [10.1016/j.jhep.2014.09.016, 10.1016/j.jhep.2014.08.009]
[19]   NFE2L2 polymorphisms, mortality, and metabolism in the general population [J].
Figarska, Sylwia M. ;
Vonk, Judith M. ;
Boezen, H. Marike .
PHYSIOLOGICAL GENOMICS, 2014, 46 (12) :411-417
[20]   Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese [J].
Fukushima-Uesaka, Hiromi ;
Saito, Yoshiro ;
Maekawa, Keiko ;
Kamatani, Naoyuki ;
Kajio, Hiroshi ;
Kuzuya, Nobuaki ;
Noda, Mitsuhiko ;
Yasuda, Kazuki ;
Sawada, Jun-ichi .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (03) :212-219